RCC2 and glioblastoma: In GBM, SARC, LUAD, and LUSC, RCC2 expression was positively related to MSI, while in LGG, KIPAN, HNSC, PAAD, and diffuse large B-cell lymphoma (DLBC), it was negatively related to MSI (Figure 8F).